Vivek Subbiah, MD

English

Dr. Vivek Subbiah is a medical oncologist at SCRI Oncology Partners and serves as the chief of early-phase drug development at SCRI. He has served as the principal investigator in over 100 phase I/II trials and as a co-investigator in over 200 clinical trials. Dr. Subbiah has authored over 350 peer-reviewed publications in several high-impact journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, JAMA Oncology, Cancer Discovery, The Lancet Oncology, Nature Reviews Clinical Oncology, The Lancet Diabetes and Endocrinology, and Clinical Cancer Research.

Dr. Vivek Subbiah is dedicated to providing access to the latest advancements in cancer treatment and clinical trials. He strives to make sure each patient’s unique needs are taken into consideration. He works with a team of multidisciplinary experts to deliver individualized treatment plans to each patient.